These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28992169)

  • 21. Points to consider in renal involvement in systemic sclerosis.
    Galluccio F; Müller-Ladner U; Furst DE; Khanna D; Matucci-Cerinic M
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v49-v52. PubMed ID: 28992172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials.
    Humbert M; Singh M; Furst DE; Khanna D; Seibold JR
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v33-v37. PubMed ID: 28992168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of inherited cardiomyopathies.
    Millar L; Sharma S
    Practitioner; 2014 Oct; 258(1775):21-5, 2-3. PubMed ID: 25591284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular manifestations in progressive systemic sclerosis].
    Badui E; Robles E; Hernández C; García Rubí D; Mintz G
    Arch Inst Cardiol Mex; 1985; 55(3):263-8. PubMed ID: 2932080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary myocardial involvement in systemic sclerosis.
    Kahan A; Allanore Y
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of cardiac involvement in systemic scleroderma, apropos of 3 cases].
    Milesi-Lecat AM; Cauhape P; Schmidt J; Marcaggi X; Peycelon P; Kemeny JL; Lusson JR; Frances C; Marcheix JC; Aumaitre O
    Rev Med Interne; 1993; 14(10):936. PubMed ID: 8009038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).
    Di Cesare E; Battisti S; Di Sibio A; Cipriani P; Giacomelli R; Liakouli V; Ruscitti P; Masciocchi C
    Eur J Radiol; 2013 Jun; 82(6):e268-73. PubMed ID: 23510727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.
    Clements P; Allanore Y; Furst DE; Khanna D
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v23-v26. PubMed ID: 28992165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiography in 110 patients with systemic sclerosis: a cross-sectional comparison with population-based controls.
    Nordin A; Björnådal L; Larsson A; Svenungsson E; Jensen-Urstad K
    Scand J Rheumatol; 2014; 43(3):221-5. PubMed ID: 24392822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial lung disease points to consider for clinical trials in systemic sclerosis.
    Khanna D; Seibold J; Goldin J; Tashkin DP; Furst DE; Wells A
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v27-v32. PubMed ID: 28992174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac complications of systemic sclerosis and management: recent progress.
    Rangarajan V; Matiasz R; Freed BH
    Curr Opin Rheumatol; 2017 Nov; 29(6):574-584. PubMed ID: 28957839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
    Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
    Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.
    Pieroni M; De Santis M; Zizzo G; Bosello S; Smaldone C; Campioni M; De Luca G; Laria A; Meduri A; Bellocci F; Bonomo L; Crea F; Ferraccioli G
    Semin Arthritis Rheum; 2014 Feb; 43(4):526-35. PubMed ID: 23932313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echographic diagnosis of cardiac involvement in systemic lupus erythematosus and systemic scleroderma.
    Sipciu D
    Rom J Intern Med; 1992; 30(2):75-81. PubMed ID: 1496265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac complications of systemic sclerosis.
    Kahan A; Coghlan G; McLaughlin V
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii45-8. PubMed ID: 19487224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis].
    Wranicz JK; Strzondała M; Zielińska M; Cygankiewicz I; Ruta J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A
    Przegl Lek; 2000; 57(7-8):389-92. PubMed ID: 11109311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis.
    Lubitz SA; Goldbarg SH; Mehta D
    Prog Cardiovasc Dis; 2008; 51(1):58-73. PubMed ID: 18634918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart involvement in systemic scleroderma].
    Gunka V; Kulhánek M
    Vnitr Lek; 1992 Jan; 38(1):79-85. PubMed ID: 1561779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of echocardiography and magnetic resonance imaging for detecting cardiac complications in systemic sclerosis. A case report.
    Cojan Minzat BO; Cioanca C; Mihalcea I; Lupu S; Agoston-Coldea L
    Med Ultrason; 2015 Jun; 17(2):262-5. PubMed ID: 26052582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.